Vaccination with genetically engineered allergens prevents progression of allergic disease

IgE-mediated allergy affects >25% of the population in industrialized countries. Repeated contact with the disease-eliciting allergens induces rises of allergen-specific IgE Abs and progression of the disease to more severe manifestations. Our study uses a type of vaccine that is based on genetic...

詳細記述

保存先:
書誌詳細
主要な著者: Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M.-T., Valent, P., Reisinger, J., Pelzmann, M., Hayek, B., Kronqvist, M., Gafvelin, G., Grönlund, H., Purohit, A., Suck, R., Fiebig, H., Cromwell, O., Pauli, G., van Hage-Hamsten, M., Valenta, R.
フォーマット: Artigo
言語:Inglês
出版事項: National Academy of Sciences 2004
主題:
Colloquium
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC521981/
https://ncbi.nlm.nih.gov/pubmed/15310844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0404735101
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料